Acadian Asset Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.23M | Buy |
127,793
+90,358
| +241% | +$4.41M | 0.01% | 530 |
|
|
2025
Q1 | $1.9M | Buy |
37,435
+2,140
| +6% | +$109K | 0.01% | 769 |
|
|
2024
Q4 | $1.59M | Buy |
35,295
+17,294
| +96% | +$780K | ﹤0.01% | 823 |
|
|
2024
Q3 | $667K | Buy |
18,001
+17,459
| +3,221% | +$647K | ﹤0.01% | 1018 |
|
|
2024
Q2 | $16K | Buy |
+542
| New | +$16K | ﹤0.01% | 1690 |
|
|
2023
Q4 | – | Sell |
-679
| Closed | -$15K | – | 1793 |
|
|
2023
Q3 | $15K | Buy |
+679
| New | +$15K | ﹤0.01% | 1572 |
|
|
2023
Q1 | – | Sell |
-539
| Closed | -$20K | – | 1921 |
|
|
2022
Q4 | $20K | Sell |
539
-822
| -60% | -$30.5K | ﹤0.01% | 1713 |
|
|
2022
Q3 | $68K | Buy |
+1,361
| New | +$68K | ﹤0.01% | 1444 |
|
|
2021
Q3 | – | Sell |
-1,464
| Closed | -$62K | – | 1960 |
|
|
2021
Q2 | $62K | Buy |
+1,464
| New | +$62K | ﹤0.01% | 1767 |
|
|
2018
Q3 | – | Sell |
-2,437
| Closed | -$82K | – | 1760 |
|
|
2018
Q2 | $82K | Sell |
2,437
-13,795
| -85% | -$464K | ﹤0.01% | 1290 |
|
|
2018
Q1 | $440K | Buy |
+16,232
| New | +$440K | ﹤0.01% | 890 |
|
|
2017
Q4 | – | Sell |
-11,762
| Closed | -$236K | – | 1655 |
|
|
2017
Q3 | $236K | Buy |
+11,762
| New | +$236K | ﹤0.01% | 883 |
|
|
2017
Q1 | – | Sell |
-25,421
| Closed | -$277K | – | 1728 |
|
|
2016
Q4 | $277K | Buy |
+25,421
| New | +$277K | ﹤0.01% | 961 |
|